Center-Authored Papers

Filters: Author is Langer, Corey J  [Clear All Filters]
E
Ettinger DS, Akerley W, Bepler G, Chang A, Cheney RT, Chirieac LR, D'Amico TA, Demmy TL, Feigenberg SJ, Figlin RA et al..  2008.  Non-small cell lung cancer.. Journal of the National Comprehensive Cancer Network : JNCCN. 6(3):228-69.
K
Kalemkerian GP, Akerley W, Downey RJ, Ettinger DS, Fossella F, Grecula JC, Jahan T, Johnson BE, Kessinger A, Koczywas M et al..  2008.  Small cell lung cancer.. Journal of the National Comprehensive Cancer Network : JNCCN. 6(3):294-314.
L
Langer CJ, Gadgeel SM, Borghaei H, Papadimitrakopoulou VA, Patnaik A, Powell SF, Gentzler RD, Martins RG, Stevenson JP, Jalal SI et al..  2016.  Carboplatin and pemetrexed with or without pembrolizumab for advanced, non-squamous non-small-cell lung cancer: a randomised, phase 2 cohort of the open-label KEYNOTE-021 study.. The Lancet. Oncology. 17(11):1497-1508. Abstract
Lara PN, Natale R, Crowley J, Lenz HJ, Redman MW, Carleton JE, Jett J, Langer CJ, Kuebler PJ, Dakhil SR et al..  2009.  Phase III trial of irinotecan/cisplatin compared with etoposide/cisplatin in extensive-stage small-cell lung cancer: clinical and pharmacogenomic results from SWOG S0124.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 27(15):2530-5. Abstract